Please check your internet connection and try again.
# Bricafem
## Overview
Bricafem is a brand name for **estradiol topical foam**. It is a topical estrogen formulation used for vulvovaginal symptoms associated with menopause.
## Primary Indications
* Treatment of moderate to severe dyspareunia (vaginal pain during intercourse) due to menopause-related vulvovaginal atrophy (VVA).
## Adult Dosing
* **Initial Dose:** Apply one applicatorful (4 grams of foam) intravaginally once daily.
* **Maintenance Dose:** After 12 weeks, if symptoms are not adequately managed, the dose may be reduced to 2 grams of foam intravaginally three times weekly.
## Pediatric Dosing
* Safety and effectiveness in pediatric patients have not been established.
## Dose Adjustments
* **Renal Impairment:** No specific dose adjustments are recommended.
* **Hepatic Impairment:** No specific dose adjustments are recommended. Use with caution in patients with known hepatic impairment.
## Contraindications
* Known or suspected breast cancer or history of breast cancer.
* Known or suspected estrogen-dependent neoplasia.
* Undiagnosed abnormal genital bleeding.
* Active deep vein thrombosis (DVT), arterial thromboembolism (e.g., stroke, myocardial infarction), or a history of these conditions.
* Protein C, Protein S, antithrombin, or other known thrombophilic disorders.
* Known history of allergic reaction to estradiol.
## Adverse Effects
* **Common:** Application site reactions (e.g., itching, burning at the application site), vaginal discomfort, breast pain, headache.
* **Serious:** Increased risk of endometrial cancer (in women with a uterus not receiving concomitant progestogen therapy), cardiovascular events (stroke, myocardial infarction), DVT, pulmonary embolism, gallbladder disease, dementia, and breast cancer.
## Key Drug Interactions
* Estrogens can affect the metabolism of other drugs, including CYP3A4 substrates (e.g., corticosteroids, cyclosporine). Concomitant use may increase plasma concentrations of these drugs.
## Monitoring
* Regular medical check-ups, including breast and pelvic examinations, are recommended.
* Monitor for signs and symptoms of VTE, cardiovascular events, and endometrial hyperplasia.
## Clinical Pearls
* Bricafem delivers estradiol directly to vaginal tissues, minimizing systemic absorption compared to oral estrogens.
* For women with a uterus, concomitant progestogen therapy should be considered to reduce the risk of endometrial hyperplasia. Local protocol should guide this decision.
* Shake the canister well before each use.
***
**Disclaimer:** This information is intended for clinical use by healthcare professionals and is not a substitute for professional medical advice. Always refer to the most current prescribing information and consult with a qualified healthcare provider for any health concerns or before making any treatment decisions.